Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|May 20, 2003
Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulationsVladimir Piotrovsky, Achiel Van Peer, Nancy Van Osselaer, et al.
Pharmacogenomics|December 24, 2008
Developing the evidence base for applying pharmacogenomics: proceeds from DIA Workshop IV--Breakout Session 1Martin Armstrong, Christina Bromley, Nadine Cohen, et al.
Joint Commission Journal on Quality and Patient Safety|April 20, 2011
High rates of venous thromboembolism prophylaxis did not increase the incidence of heparin-induced thrombocytopeniaIan Jenkins, Pieter J Helmons, Leslie M Martin-Armstrong, et al.
Brain : a Journal of Neurology|March 18, 2021
Towards realizing the vision of precision medicine: AI based prediction of clinical drug responseJohann de Jong, Ioana Cutcutache, Matthew Page, et al.
Human Genetics|June 3, 2021
Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)Karina Bienfait, Aparna Chhibber, Jean-Claude Marshall, et al.
Scientific Reports|February 21, 2023
Artificial intelligence-based clustering and characterization of Parkinson's disease trajectoriesColin Birkenbihl, Ashar Ahmad, Nathalie J Massat, et al.
Circulation. Cardiovascular Genetics|November 17, 2010
First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studiesUdaya S Tantry, Kevin P Bliden, Cheryl Wei, et al.
Platelets|June 14, 2006
Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapySimon M G Smith, Heather M Judge, Gary Peters, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Nature Communications|May 28, 2024
An isoform quantitative trait locus in SBNO2 links genetic susceptibility to Crohn's disease with defective antimicrobial activityDominik Aschenbrenner, Isar Nassiri, Suresh Venkateswaran, et al.
Pageof 3